Long-term intracavernous self-injection with prostaglandin E1 for the treatment of erectile dysfunction

International Journal of Andrology

Volumn 19, Issue 1, 1996, Pages 28-32

  Canale, D ^a   Giorgi, P M ^a   Lencioni, R ^a   Morelli, G ^a   Gasperi, M ^a   Macchia, E ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Erectile dysfunction; Intracavernous treatment; Penile fibrosis; Prostaglandin E1

Indexed keywords

PROSTAGLANDIN E1; VASOACTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CORPUS CAVERNOSUM; FIBROSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PENIS DISEASE; PENIS ERECTION; PRIORITY JOURNAL; ULTRASOUND;

EID: 0029962922     PISSN: 01056263     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2605.1996.tb00430.x     Document Type: Article

References (21)

1. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. & McKinlay, J. B. (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology, 151, 54-61.
2. Girdley, F. M., Bruskewitz, R. C., Feyzi, J., Graversen, P. H. & Gasser, T. C. (1988) Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients. Journal of Urology, 140, 972-974.
3. Ishii, N., Watanabe, H., Irisawa, C., Kikuchi, Y., Kawamura, S.; Suzuki, K., Chiba, R., Tokiwa, M. & Shirai, M.(1986) Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence. Japan Journal of Urology, 77, 954-957.
4. Ishii, N., Watanabe, H., Irisawa, C., Kikuchi, Y., Kubota, Y., Kawamura, S., Suzuki, K., Chiba, R., Tokiwa, M. & Shirai, M.(1989) Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence. Journal of Urology, 141, 323-325.
5. Krane, R. J., Goldstein, I., Saenz de Tejada, I (1989) Impotence. New England Journal of Medicine, 321, 1648-1659.
6. Lakin, M. M., Montague, D. K., VanderBrug Medendorp, S., Tesar, L. & Schover, L. R. (1990) Intracavernous injection therapy: analysis of results and complications. Journal of Urology, 143, 1138-1141
7. Lakin, M. M., Chen, R. N. & Montague, D. K. (1994) Risk factors for penile fibrosis while using intracavernous injection therapy with prostaglandin E1. Journal of Urology, 151, Suppl. AUA 89th Annual Meeting, abs. 914, 456A.
8. Levine, S. B., Althof, S. E., Turner, L. A., Risen, C. B., Bodner, D. R., Kursh, E. D. & Resnick M. I. (1989) Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. Journal of Urology, 141, 54-57.
9. Montorsi, F., Guazzoni, G., Bergamaschi, F., Dodesini, A., Rigatti, P., Pizzini, G. & Miani, A. (1993) Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Urology, 42, 554-558.
10. National Institutes of Health Consensus Conference on Impotence (1993) Journal of the American Medical Association, 270, 83-90.
11. Padma-Nathan, H., Goldstein, I., Payton, T. & Krane, R. J. (1987) Intracavernosal pharmacotherapy: the pharmacologic erection program. World Journal of Urology, 5, 160-165.
12. Porst, H. (1993) Experience with alprostadil in diagnosis and therapy in Germany. In: The Role of Alprostadil in the Diagnosis and Treatment of Erectile Dysfunction (eds I. Goldstein and T. F. Lue), pp 142-154. Excerpta Medica, Princeton, NJ.
13. Schrey, A. (1990) Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities. Fortschritte der Medizin, 108, 577-580.
14. Slag, M. F., Motley, J. E., Elson, M. K., Trence, D. L., Nelson, C. J., Nelson, A. E., Kinlaw, W. B., Beyer, S., Nuttall, F. Q. & Shafer, R. B. (1983) Impotence in medical clinic patients. Journal of the American Medical Association, 249, 1736-1740.
15. Stackl, W., Hasun, R. & Marherger, M. (1988) Intracavernous injection of prostaglandin E1 in impotent men. Journal of Urology, 140, 66-68.
16. Virag, R. (1982) Intracavernous injection of papaverine for erectile failure. Lancet, ii, 938.
17. Virag, R., Shoukry, K, Floresco, J., Nollet, F. & Greco, E. (1991) Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. Journal of Urology, 145, 287-292.
18. Virag, R., Nollet, E, Greco, E. & Shoukry, K. (1993) Dynamic echography of the penis in the follow-up of impotent patients treated with intracavernous injections. British Journal of Urology, 72, 809-816.
19. Waldhauser, M. & Schramek, P. (1988) Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction. Journal of Urology, 140, 525-528.
20. Zentgraf, M., Baccouche, M. & Junemann, K. P. (1988) Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine. Urology International, 43, 65-75.
21. Zorgniotti, A. W. & Lefleur, R. S. (1985) Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. Journal of Urology, 133, 39-41.